Cheap Clinical Biomarker May Predict Long COVID Severity in Older Women

You May Be Interested In:7 Signs It’s Time to Take Your Memory Problems Seriously



(MedPage Today) — Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.
According to data on 1,237 Women’s Health…

share Paylaş facebook pinterest whatsapp x print

Similar Content

Endo Break over a computer rendering of a man with illustrated body organs.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?
A young child receiving a vaccine from a female doctor
Montana May Start Collecting Immunization Data Again Amid US Measles Outbreak – KFF Health News
FDA blocks import of papaya from Mexico, tamarind from all countries
Chicken quesadillas
Baby’s head shape: Cause for concern?
A computer rendering of a transparent brain with the amygdala highlighted.
Novel PTSD Treatment Improved Symptom Severity in Phase IIb Trial
A photo of Robert F. Kennedy Jr. walking down a hallways surrounded by reporters and a TV news camera.
What RFK Jr. Might Face in His Nomination Hearings This Week – KFF Health News
Headline Horizon | © 2025 | News